Literature DB >> 10458339

Percutaneous stone removal in horseshoe kidneys.

K Al-Otaibi1, D H Hosking.   

Abstract

PURPOSE: We review our experience with percutaneous nephrolithotomy for stones in horseshoe kidneys when extracorporeal shock wave lithotripsy was unsuccessful or inappropriate because of stone burden.
MATERIALS AND METHODS: Stone burden, nephrostomy and percutaneous surgical techniques, and clinical outcome of 12 consecutive patients undergoing percutaneous nephrolithotomy for calculi in horseshoe kidneys between 1988 and 1997 were reviewed.
RESULTS: Complete stone removal was achieved by percutaneous methods alone in 9 patients (75%). More than 1 nephrostomy tract was required in 5 patients and additional intraoperative nephrostomies were necessary in 4. Flexible nephroscopy was essential in achieving complete stone removal in 9 of 11 patients (82%). Second look procedures for stone removal were required in 3 patients. No sepsis occurred and no transfusions were needed.
CONCLUSIONS: Percutaneous nephrolithotomy is a safe and effective method of stone removal in patients with calculi in horseshoe kidneys. Multiple nephrostomy tracts, the use of flexible nephroscopy and second look procedures may be necessary to achieve optimum stone removal.

Entities:  

Mesh:

Year:  1999        PMID: 10458339     DOI: 10.1097/00005392-199909010-00009

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  ESWL in the treatment of stone in child with horseshoe kidney.

Authors:  A Slavkovió; M Vlajković; M Radovanović; Z Sirić; V Stefanović
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Difficulties with access in percutaneous renal surgery.

Authors:  Soroush Rais-Bahrami; Justin I Friedlander; Brian D Duty; Zeph Okeke; Arthur D Smith
Journal:  Ther Adv Urol       Date:  2011-04

3.  Mini-percutaneous nephrolithotomy for stones in anomalous-kidneys: a prospective study.

Authors:  Sanjay Khadgi; Babu Shrestha; Hamdy Ibrahim; Sunil Shrestha; Mohammed S ElSheemy; Ahmed M Al-Kandari
Journal:  Urolithiasis       Date:  2016-10-04       Impact factor: 3.436

4.  Retrograde nephrostomy access for percutaneous nephrolithotomy: a simple and safe technique.

Authors:  Khalid M Alotaibi
Journal:  Urolithiasis       Date:  2019-04-29       Impact factor: 3.436

5.  Percutaneous nephrolithotomy in horseshoe kidney: comparing ultrasound-guided access in flank position with conventional fluoroscopic-guided in prone position.

Authors:  Seyed Hassan Inanloo; Seyed Reza Yahyazadeh; Mahdi Ramezani-Binabaj
Journal:  Urolithiasis       Date:  2022-10-14       Impact factor: 2.861

Review 6.  [Diagnosis and treatment of nephrolithiasis. What is established?].

Authors:  A Pfau; K-U Eckardt; F Knauf
Journal:  Internist (Berl)       Date:  2015-12       Impact factor: 0.743

7.  Ureteroscopy-assisted retrograde nephrostomy for lower calyx calculi in horseshoe kidney: two case reports.

Authors:  Takashi Kawahara; Hiroki Ito; Hideyuki Terao; Katsuyuki Tanaka; Takehiko Ogawa; Hiroji Uemura; Yoshinobu Kubota; Junichi Matsuzaki
Journal:  J Med Case Rep       Date:  2012-07-10

8.  Postpercutaneous nephrolithotomy nephrostogram: is it mandatory? A single center experience.

Authors:  Abdul Rouf Khawaja; Tanveer Iqbal Dar; Ajay Kumar Sharma; Farzana Bashir; Vipin Kumar Tyagi; Mohammad Sajid Bazaz
Journal:  Adv Urol       Date:  2014-02-03

9.  Percutaneous nephrolithotomy in horseshoe kidneys: is rigid nephroscopy sufficient tool for complete clearance? A case series study.

Authors:  Mohamed N El Ghoneimy; Ahmed S Kodera; Ashraf M Emran; Tamer Z Orban; Ahmed M Shaban; Mohamed M El Gammal
Journal:  BMC Urol       Date:  2009-11-16       Impact factor: 2.264

10.  Effectiveness of ureteroscopy-assisted retrograde nephrostomy (UARN) for percutaneous nephrolithotomy (PCNL).

Authors:  Takashi Kawahara; Hiroki Ito; Hideyuki Terao; Yoshitake Kato; Hiroji Uemura; Yoshinobu Kubota; Junichi Matsuzaki
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.